Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2

American Journal of Pathology

Volumn 155, Issue 3, 1999, Pages 995-1004

  Kelley, Kevin A ^a   Ho, Lap ^a   Winger, David ^a   Freire Moar, Jose ^b   Borelli, Cy Blanco ^a   Aisen, Paul S ^c   Pasinetti, Giulio Maria ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Rocbe Bioscience   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; EXCITATORY AMINO ACID RECEPTOR; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ENZYME INHIBITION; GENE EXPRESSION; GENE OVEREXPRESSION; HIPPOCAMPUS; IMMEDIATE EARLY GENE; MOUSE; NERVE DEGENERATION; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0032887341     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65199-1     Document Type: Article

References (54)

1. Marnett L: Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 1992, 52:5575-5589
2. Meade EA, Smith WL, DeWitt DL: Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1993, 268:6610-6614
3. Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR, TIS10, a phorbol ester promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 1991, 266:12866-12872
4. O'Banion MK, Winn VD, Young DA: CDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc Natl Acad Sci USA 1991, 89:4888-4892
5. Cao C, Matsumura K, Yamagata K, Watanabe Y: Induction by lipopolysaccharide of cyclooxygenase-2 mRNA in rat brain: Its possible role in the febrile response. Brain Res 1995, 697:187-196
6. Giovanucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC: Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 1994, 121:241-246
7. Greenberg ER, Baron JA, Freeman DHJ, Mandel JS, Haile, R: Reduced risk of large-bowel adenomas among aspirin users: the polyp prevention study group. J Natl Cancer Inst 1993, 85:912-916
8. Thun MJ, Namboodiri MM, Heath CW, Jr: Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991, 325:1593-1596
9. Thun MJ, Namboodiri MM, Calle E, Flanders W, Heath CJ: Aspirin use and risk of fatal cancer. Cancer Res 1993, 53:1322-1327
10. McGeer PL, Schulzer M, McGeer EG: Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 1996, 47:425-443
11. Pasinetti GM: Cyclooxygenase and inflammation in Alzheimer's disease: experimental approaches and clinical interventions. J Neurosci Res 1998, 54:1-6
12. Tocco G, Freire-Moar J, Schreiber SS, Sakhi SH, Aisen PS, Pasinetti GM. Maturational regulation, and regional induction of cyclooxygenase-2 in rat brain: Implications for Alzheimer's disease. Exp Neurol 1997, 144:399-349
13. Olney JW, Wozniak DF Farber NB: Excitotoxic neurodegeneration in Alzheimer disease: new hypothesis and new therapeutic strategies. Arch Neurol 1997, 54:1234-1240
14. Pasinetti GM, Aisen PS: Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain. Neuroscience 1998, 87: 319-324
15. Oka A, Takashima S: Induction of cyclo-oxygenase 2 in brains of patients with Down's syndrome and dementia of Alzheimer type: specific localization in affected neurones and axons. Neuroreport 1997, 8:1161-1164
16. Adams J, Collaco-Moraes Y, de Belleroche J: Cyclooxygenase-2 induction in cerebral cortex: an intracellular response to synaptic excitation. J Neurochem 1996, 66:6-12
17. Hia T, Nielsen N: Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 1992, 89:7384-7388
18. Mucke L, Masliah E, Johnson, WB, Ruppe MD, Alford M, Rockenstein, EM, Forss-Petter S, Pietropaolo M, Mallory M, Abraham CR: Synaptotrophin effects of human amyloid β protein precursors in the cortex of transgenic mice. Brain Res 1994, 666:151-167
19. Hogan B, Costantini F, Lacy E: Manipulating the Mouse Embryo: A Laboratory Handbook. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1986
20. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochem 1979, 18:5294-5301
21. Lehrach H, Diamond D, Wozney JM, Boedtker H: RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical examination. Biochemistry 1977, 16:4743-4751
22. Schreiber SS, Maren S, Tocco G, Shors TJ, Thompson RF: A negative correlation between the induction of long-term potentiation and activation of immediate early genes. Mol Brain Res 1991, 11:89-91
23. Schreiber SS, Tocco G, Najm, I, Thompson RF, Baudry M: Cycloheximide prevents kainate-induced neuronal death and c-fos expression in adult rat brain. J Mol Neurosci 1993, 4:149-159
24. Ho L, Osaka H, Aisen PS, Pasinetti GM: Induction of cyclooxygenase (COX)-2 but not COX-1 gene expression in apoptotic cell death. J Neuroimmunol 1998, 89:142-149
25. Pasinetti GM: In situ hybridization to brain tissue sections using labeled single-strand complememtary RNA probes. Methods in Molecular Biology, vol. 13: Protocols in Molecular Neurobiology. Edited by A Longstaff and P Revest. Totowa, NJ, Humana Press, 1992, pp 155-165
26. Pasinetti GM, Johnson SA, Oda T, Rozovsky I, Finch CE. Clusterin (SGP-2): a multifunctional glycoprotein with regional expression in astrocytes and neurons of the adult rat brain. J Comp Neurol 1994, 339:387-400
27. Tocco G, Musleh W, Sakhi S, Schreiber SS, Baudry M, Pasinetti, GM: Complement and glutamate neurotoxicty. Genotypic influences of C5 in a mouse model of hippocampal neurodegeneration Mol Chem Neuropathol 1997, 31:289-299
28. Kondo T, Sharp FR, Honkaniemi J, Mikawa S, Epstein CJ, Chan PH: DNA fragmentation and prolonged expression of c-fos, c-jun, and hsp-70 in kainic acid-induced neuronal cell death in transgenic mice overexpressing human CuZn-superoxide dismutase. J Cereb Blood Flow Metab 1997, 17:241-256
29. Castillo MB, Celio MR, Andressen C, Gotzos V, Rulicke T, Berger MC, Weber J, Berchtold MW: Production and analysis of transgenic mice with ectopic expression of parvalbumin. Arch Biochem Biophys 1995, 317:292-298
30. Colucci-D'Amato GL, Santelli G, D'Alessio A, Chiappetta G, Mineo A, Manzo G, Vecchio G, DeFranciscis V: Dbl expression driven by the neuron-specific enolase promoter induces tumor formation in transgenic mice with a p53(±) background. Biochem Biophys Res Commun 1995, 216:762-770
31. Farlie PG, Dringen R, Rees SM, Kannourakis G, Bernard O: Bcl-2 transgene expression can protect neurons against developmental and induced cell death. Proc Natl Acad Sci USA 1995, 92:4397-4401
32. Fattori E, Lazzaro D, Musiani P, Modesti A, Alonzi, T, Ciliberto G: IL-6 expression in neurons of transgenic mice causes reactive astrocytosis and increase in ramified microglial cells but no neuronal damage. Eur J Neurosci 1995, 7:2441-2449
33. Forss-Petter S, Danielson PE, Catsicas S, Battenberg E, Price J, Nerenberg M, Sutcliffe JG: Transgenic mice expressing β-galactosidase in mature neurons under neuron-specific enolase promoter control. Neuron 1990, 5:187-197
34. Malherbe P, Richards JG, Martin JR, Bluethmann H, Maggio J, Huber G: Lack of β-amyloidosis in transgenic mice expressing low levels of familial Alzheimer's disease missense mutations. Neurobiol Aging 1996, 17:205-214
35. Martinou JC, Dubois-Dauphin M, Staple JK, Rodriguez I, Frankowski H, Missotten M, Albertini P, Talabot D, Catsicas S, Pietra C: Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 1994, 13: 1017-1030
36. Rall GF, Mucke L, Oldstone MB: Consequences of cytotoxic T lymphocyte interaction with major histocompatibility complex class l-expressing neurons in vivo. J Exp Med 1995, 182:1201-1212
37. Zhao J, Paganini L, Mucke L, Gordon M, Refolo L, Carman M, Sinha S, Oltersdorf T, Lieberburg I, McConlogue L: β-secretase processing of the β-amyloid precursor protein in transgenic mice is efficient in neurons but inefficient in astrocytes. J Biol Chem 1996, 271:31407-31411
38. Sakimura K, Kushiya E, Ogura A, Kudo Y, Katagiri T, Takahashi Y: Upstream and intron regulatory regions for expression of the rat neuron-specific enolase gene. Mol Brain Res 1995, 28:19-28
39. Prescott SM, White R: Self promotion? Intimate connections between APC and prostaglandin H synthase-2. Cell 1996, 87:783-786
40. Marcheselli V, Bazan NG: Sustained induction of prostaglandin endoperoxide synthase-2 by seizures in hippocampus-Inhibition by a platelet-activating factor antagonist. J Biol Chem 1996, 271:24794-24799
41. Bazan NG: A signal terminator. Nature 1995, 374:501-502
42. Janssen-Timmen V, Lemaire P, Mattei M, Relevant O, Charnay P: Structure chromosome mapping and regulation of the mouse zinc finger gene krox-24: evidence for a common regulatory pathway for immediate early serum response genes. Gene 1989, 80:325-336
43. Simonato M, Hosford D, Labiner D, Shin C, Mansbach HH, McNamara J: Differential expression of immediate early genes in the hippocampus in the kindling model of epilepsy. Mol Brain Res 1991, 11:115-124
44. ++ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J Neurochem 1995, 65:1740-1751
45. Murakami M, Nakatani Y, Atsumi G, Inoue K, Kudo I: Regulatory functions of phospholipase A2. Crit Rev Immunol 1997, 217:225-283
46. Kimura H, Okamoto K, Sakai Y: Modulatory effects of prostaglandin D2, E2 and F2 on the postsynaptic action of inhibithory and excitatory amino acids in cerebellar Purkinje cells dendrites in vitro. Brain Res 1985, 330:235-244
47. Hewett SJ, Hewett JA: COX-2 contributes to NMDA-induced neuronal death in cortical cell cultures. Soc Neurosci 1997 (meeting abstr), 23:1666
48. Cazevieille C, Muller A, Meynier F, Dutrait N, Bonne C: Protection by prostaglandin from glutamate toxicity in cortical neurons. Neurochem Int 1994, 24:395-398
49. Halliwell B, Gutteridge JMC: Free Radical in Biology and Medicine, 3rd edition. Oxford, Clarendon Press, 1995
50. Dawson VL, Dawson TM, London E, Bredt DS, Snyder SH: Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci USA 1991, 88:6368-6371
51. Cazevieille C, Muller A, Meynier F, Bonne C: Superoxide and nitric oxide cooperation in hypoxia reoxygenation-induced neuron injury. Free Rad Biol Med 1993, 14:389-395
52. Patel M, Day BJ, Crapo JD, Fridovich I, McNamara JO: Requirement for superoxide in excitotoxic cell death. Neuron 1996, 16:345-355
53. Murphy TH, Miyamoto M, Sastre A, Schnaar RL, Coyle JT: Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 1989, 2:1547-1558
54. Shoami, E, Rosenthal, J., Lavy S: The effect of incomplete cerebral ischemia on prostaglandin levels in rat brain. Stroke 1982, 13:494-499